Hereditary Colon Cancer: Lynch Syndrome

참고문헌 (43)

1. Jenkins MA, "Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study", Cancer Epidemiol Biomarkers Prev, 15, pp.312~314 (2006)
2. Hampel H, "Feasibility of screening for Lynch syndrome among patients with colorectal cancer", J Clin Oncol, 26, pp.5783~5788 (2008)
3. Gylling A, "Large genomic rearrangements and germline epimutations in Lynchsyndrome", Int J Cancer, 124, pp.2333~2340 (2009)
4. Suter CM, "Germline epimutation of MLH1 in individuals with multiple cancers", Nat Genet, 36, pp.497~501 (2004)
5. Hitchins M, "MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer", Gastroenterology, 129, pp.1392~1399 (2005)
6. exons of TACSTD1, "Nat Genet", 2009, 112~117
7. Rijcken FE, "Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation", Gut, 50, pp.382~386 (2002)
8. Hampel H, "Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset", Gastroenterology, 129, pp.415~421 (2005)
9. Lindor NM, "Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review", JAMA, 296, pp.1507~1517 (2006)
10. Quehenberger F, "Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment", Journal of Medical Genetics, 42, pp.491~496 (2005)
11. Choi YH, "Penetrance of colorectal cancer among MLH1", MSH2 carriers participating in the colorectal cancer familial registry in Ontario, 2009, pp.7, 14~
12. Kastrinos F, "Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States", Cancer Epidemiol Biomarkers Prev, 17, pp.2044~2051 (2008)
13. Goecke T, "Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium", J Clin Oncol, 24, pp.4285~4292 (2006)
14. Kruse R, "Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria", Am J Hum Genet, 63, pp.63~70 (1998)
15. Mangold E, "A genotype- phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome", J Med Genet, 41, pp.567~572 (2004)
16. Kruse R, "Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene?", Hum Genet, 98, pp.747~750 (1996)
17. Geary J, "Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)", Fam Cancer, 7, pp.163~172 (2008)
18. Watson P, "The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome", Int J Cancer, 123, pp.444~449 (2008)
19. Chhibber V, "MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome", Modern Pathology, 21, pp.159~164 (2008)
20. Hendriks YM, "Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance", Gastroenterology, 127, pp.17~25 (2004)
21. Baglietto L, "Risks of Lynch syndrome cancers for MSH6 mutation carriers", J Natl Cancer Inst, 102, pp.193~201 (2010)
22. Senter L, "The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations", Gastroenterology, 135, pp.419~428 (2008)
23. Chang DK, "Steady-state regulation of the human DNA mismatch repair system", J Biol Chem, 275, pp.18424~18431 (2000)
24. Chang DK, "Diagnostic and therapeutic strategy for the HNPCC patients and their family", Intestinal Research, 4, pp.168~176 (2006)
25. Berends MJ, "Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant", Am J Hum Genet, 70, pp.26~37 (2002)
26. Chung D, "The hereditary nonpolyposis colorectal cancer syndrome: genetic and clinical implication", Ann Intern Med, 138, pp.560~570 (2003)
27. Hendriks YM, "Diagnostic approach and management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): a guide for clinicians", CA Cancer J Clin, 56, pp.213~225 (2006)
28. Deng G, "BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer", Clin Cancer Res, 10, pp.191~195 (2004)
29. Domingo E, "BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes", Oncogene, 24, pp.3995~3998 (2005)
30. Schofield L, "Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test", Int J Cancer, 124, pp.1097~1102 (2009)
31. Lynch HT, "Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review", Cancer, 78, pp.1149~1167 (1996)
32. Burke W, "Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium", JAMA, 19, pp.915~919 (1997)
33. Renkonen-Sinisalo L, "No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer", Scand J Gastroenterol, 37, pp.574~577 (2002)
34. Gritz ER, "Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer", J Clin Oncol, 23, pp.1902~1910 (2005)
35. Jarvinen HJ, "Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer", Gastroenterology, 108, pp.1405~1411 (1995)
36. Jarvinen HJ, "Controlled15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer", Gastroenterology, 118, pp.829~834 (2000)
37. Aarnio M, "Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome", Int J Cancer, 64, pp.430~433 (1995)
38. Dunlop MG, "Cancer risk associated with germline DNA mismatch repair gene mutations", Hum Mol Genet, 6, pp.105~110 (1997)
39. Aarnio M, "Cancer risk in mutation carriers of DNA-mismatch-repair genes", Int J Cancer, 81, pp.214~218 (1999)
40. Vasen HF, "MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families", J Clin Oncol, 19, pp.4074~4080 (2001)
41. Schulmann K, "Small bowel cancer risk in Lynch syndrome", Gut, 57, pp.1629~1630 (2008)
42. "Globocan 2002"[URL]
43. Grady WM, "Genomic and epigenetic instability in colorectal cancer pathogenesis", Gastroenterology, 135, pp.1079~1099 (2008)

관련 논문AI추천